Default Image
2, Jul 2026
Govt-Industry Meet Focuses on Global Growth of AYUSH Sector

New Delhi, July 2: The Government of India and key industry stakeholders held discussions to outline a roadmap for strengthening India’s global leadership in the AYUSH sector, focusing on Ayurveda, Yoga, Unani, Siddha, and Homoeopathy systems of medicine.

The meeting highlighted the need to enhance research, innovation, quality standards, and global outreach to promote AYUSH products and services in international markets. Officials and industry representatives discussed ways to improve regulatory frameworks, boost exports, and encourage investment in traditional medicine systems.

Participants emphasized the growing global acceptance of holistic healthcare practices and the importance of positioning India as a leading hub for traditional medicine and wellness solutions.

The discussions also focused on strengthening collaboration between government bodies, research institutions, and industry players to support scientific validation and international recognition of AYUSH practices.

Officials stated that the roadmap aims to expand global market access while ensuring quality, safety, and credibility of AYUSH products and services.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Researchers played music to cells – aggressiveness of laryngeal cancer decreased

  Mar 04: The continuous movement of the vocal cords weakens and eventually stops as laryngeal cancer progresses. Researchers have,…

Kauvery Hospitals Highlights Importance of Early Access to Level I Trauma Care on World Head Injury Awareness Day

Chennai, Mar 17th: Marking World Head Injury Awareness Day (March 20), the Kauvery Group of Hospitals emphasised the critical importance of rapid access to Level I Trauma Care Centres for patients suffering from severe head injuries and other…

Beyond the Fever: Thyrocare Study Shows Nearly 1 in 3 Indian Fever Patients Test Positive for Serious Infections

Mumbai, Mar 27:  Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has released…